文献速递临床试验与 GCP

膝关节骨关节炎患者髌下脂肪垫糖皮质激素注射的疗效与安全性:GLITTERS随机对照试验方案

Efficacy and safety of GLucocorticoid injections into InfrapaTellar faT pad in patients with knee ostEoarthRitiS: protocol for the GLITTERS randomized controlled trial.
PubMed 文献 · Trials · 2023-01-03

GLITTERS是一项多中心、双盲、随机、安慰剂对照试验,纳入60例同时存在Hoffa滑膜炎和积液性滑膜炎的膝骨关节炎患者,随机等分为糖皮质激素组和对照组,均行髌下脂肪垫注射(激素或生理盐水),并以关节腔内透明质酸注射为背景治疗,随访4、8、12周。主要结局为视觉模拟量表膝痛变化和MRI测量的积液性滑膜炎体积变化。

要点

  • GLITTERS为多中心、双盲、随机、安慰剂对照试验,计划纳入60例炎性表型膝骨关节炎患者。
  • 两组均接受髌下脂肪垫注射(糖皮质激素或生理盐水),并以关节腔内透明质酸注射为背景治疗。
  • 主要结局为12周内视觉模拟量表膝痛变化和MRI测量的积液性滑膜炎体积变化。

核心结论

  • GLITTERS试验可能为超声引导下髌下脂肪垫糖皮质激素注射在炎性膝骨关节炎患者中的短期疗效和安全性提供高质量证据。
  • 该试验结果有望为未来评估该治疗更长期的风险-获益特征提供可靠参考。

研究设计与样本

  • 多中心、双盲、随机、安慰剂对照临床试验。
  • 计划纳入60例同时存在Hoffa滑膜炎和积液性滑膜炎的膝骨关节炎患者,随机等分至糖皮质激素组或对照组。
  • 两组在基线时均接受髌下脂肪垫注射(糖皮质激素或生理盐水),并以关节腔内透明质酸注射为背景治疗,随访4、8、12周。
  • 主要结局为视觉模拟量表膝痛变化和MRI测量的积液性滑膜炎体积变化。
  • 次要结局包括西安大略和麦克马斯特大学骨关节炎指数总分变化、MRI检测的Hoffa滑膜炎评分、生活质量、止痛药使用、髌下脂肪垫体积及不良反应发生率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knee osteoarthritis (OA) is a prevalent disabling disorder that involves changes in articular cartilage damage, subchondral bone remodeling, synovitis, and abnormal infrapatellar fat pad (IPFP). Due to the complicated etiology and numerous phenotypes of knee OA, limited improvement is achieved for treatments among knee OA patients with different phenotypes. Inflammatory OA phenotype is a typical knee OA phenotype, and individualized treatment targeting inflammation is a promising way to obtain an optimal therapeutic effect for people with inflammatory knee OA phenotype. Glucocorticoid is a traditional anti-inflammatory drug for knee OA, and intra-articular glucocorticoid injections are recommended clinically. However, emerging evidence has shown that repeated intra-articular glucocorticoid injections in the long term would induce cartilage loss. IPFP and its adjacent synovium are considered as the main source of inflammation in knee OA. This GLITTERS trial aims to investigate if a glucocorticoid injection into the IPFP is effective and safe over 12 weeks among knee OA patients with an inflammatory phenotype. METHODS: GLITTERS is a multicenter, double-blinded, randomized, and placebo-controlled clinical trial among knee OA patients with both Hoffa-synovitis and effusion-synovitis. Sixty participants will be allocated randomly and equally to either the glucocorticoid group or the control group. Each group will receive an injection of glucocorticoid or saline into the IPFP with an intra-articular hyaluronic acid injection as a background treatment at baseline and be followed at 4, 8, and 12 weeks. The primary outcomes will be changes in knee pain on a visual analog scale and effusion-synovitis volume measured on magnetic resonance imaging (MRI). The secondary outcomes will be changes in the total score of Western Ontario and McMaster Universities Osteoarthritis Index score, MRI-detected Hoffa-synovitis score, quality of life, pain medication use, IPFP volume, and the incidence of adverse reactions. Data analyses based on the intention-to-treat principle will include mixed-effects regressions, Wilcoxon rank-sum tests, and chi-square tests (or Fisher's exact test). DISCUSSION: GLITTERS may provide high-quality evidence for the efficacy and safety of ultrasound-guided glucocorticoid injections into IPFP among people with inflammatory knee OA in a short term. The results of this trial are expected to provide a reliable reference for a longer-term risk-benefit profile of this treatment in the future. TRIAL REGISTRATION: ClinicalTrials.gov NCT05291650. Registered on 23 March 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Ruan G, Zheng P, et al. Efficacy and safety of GLucocorticoid injections into InfrapaTellar faT pad in patients with knee ostEoarthRitiS: protocol for the GLITTERS randomized controlled trial. Trials. 2023. PMID: 36597103. doi:10.1186/s13063-022-06993-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。